Lataa...
Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015
BACKGROUND: Gastric cancer (GC) is a highly heterogeneous disease with few “targeted” therapeutic options. Previously, we demonstrated involvement of the transcription factor HNF4α in human GC tumours, and the developmental signal mediator, WNT5A, as a prognostic GC biomarker. One previously develop...
Tallennettuna:
| Julkaisussa: | Br J Cancer |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461897/ https://ncbi.nlm.nih.gov/pubmed/30792535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0374-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|